Following a pair of similar deals in January and June, Coherus BioSciences has netted itself a hefty chunk of change for the last biosimilar in its portfolio, in turn freeing up the company to go ...
PISCATAWAY, N.J., [February 10, 2026]: Kashiv BioSciences, LLC (“Kashiv”) a vertically integrated biopharmaceutical company, today announced that it has entered into an exclusive licensing and supply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results